People · Operator
Named in public records as an officer, director or promoter · active 2026–2026 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| IceCure Medical Ltd. | Executive Officer | Biotechnology | Series B | $16.5M | $50.2M | 2026 |
| IceCure Medical Ltd. | — | Biotechnology | Seed | $8.0M | $7.4M | 2026 |
Shay Levav at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Shay Levav on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Ron Mayron | 2 | 6 |
| Vincent Chun Hung Chan | 2 | 2 |
| Sharon Levita | 2 | 2 |
| Shad Good | 2 | 2 |
| Eyal Shamir | 2 | 2 |
| Yang Huang | 2 | 2 |
| Merav Nir Dotan | 2 | 2 |
| Tlalit Bussi Tel-Tzure | 2 | 2 |
| Doron Cohen | 1 | 3 |
| Doron Birger | 1 | 3 |
| Yaacov Goldman | 1 | 3 |
| Adi Goldin | 1 | 2 |
| Yonatan Malca | 1 | 2 |
| William Irby | 1 | 2 |
| Elka Nir | 1 | 2 |
| Alon Dumanis | 1 | 1 |
| Ronen Tsimerman | 1 | 1 |
| Naum Muchnik | 1 | 1 |
| Oded Tamir | 1 | 1 |
| Nir Bachman | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.